Celularity (CELU) Revenue (2020 - 2026)
Celularity's Revenue was $5.43 million in Q2 2026, down 5.3% from $5.74 million a year earlier but up 41.2% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Revenue (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Celularity's Revenue was $18.67 million through Jun 30, 2026, down 58.1% year-over-year; for FY2025, it came in at $26.55 million, down 51.0% from FY2024.
- Revenue shows a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- In earlier years, Revenue was $54.22 million in FY2024 (+138.1%), $22.77 million in FY2023 (+26.7%), $17.98 million in FY2022 (-15.7%) and $21.34 million in FY2021 (+49.4%).
- Quarterly Revenue has moved between $2.94 million (Q2 2023) and $18.13 million (Q4 2024) over five years.
- Compared with a year earlier, Revenue has declined for six straight quarters, with an average decline of 9.0% over the last eight quarters.
- The best year-over-year quarter for Revenue over five years was Q2 2024 (growth of 312.2%); the worst was Q4 2025 (a decline of 77.4%).
- Per Business Quant data, CELU's Revenue in the three quarters before Q2 2026 was $3.85 million (Q1 2026), $4.1 million (Q4 2025) and $5.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Celularity | 30.37 Mn | 23.12 Mn | 3.09 Mn | 5.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.43 Mn |
| Mar 31, 2026 | 3.85 Mn |
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 11.43 Mn |
| Dec 31, 2024 | 18.13 Mn |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 12.11 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | 12.11 Mn |
| Sep 30, 2023 | 3.79 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 4.86 Mn |
| Sep 30, 2021 | 10.62 Mn |
API Access
Celularity Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();